Study guide

18.2 Stereotactic and Ultrasound-Guided Biopsy

ARRT Mammography Postprimary

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Postprimary Eligibility, Structured Education, and Clinical Requirements 1.3 Scoring, Retakes, Fees, and Credential Maintenance 1.4 2025 Content Outline, Domain Weights, and Study Strategy

2 Patient Communication

2.1 Pre-Exam Instructions 2.2 Explaining the Exam, Rapport, and Support 2.3 Patient Education: ACS/ACR Guidelines, BSE, CBE, Dose, and Modalities

3 Results Communication and Breast Cancer Risk

3.1 Process for Receiving Results and Additional Imaging 3.2 Epidemiology and Inherent Risk Factors 3.3 Social Risk Factors, Access, and Hormone Use 3.4 Signs and Symptoms of Breast Disease

4 History, Priors, and Treatment Context

4.1 Medical History, Physical Findings, and Gender Affirmation 4.2 Previous Mammograms 4.3 Surgical, Nonsurgical, and Reconstruction Options

5 Mammography Unit Design

5.1 kVp Range, Tube, Filtration, Window, and Focal Spot 5.2 Compression Paddles, Grids, and System Geometry

6 Digital Acquisition, Display, and Informatics

6.1 FFDM-DR/2D, DBT/3D, and Synthesized Imaging 6.2 Image Receptors and Acquisition vs Interpretation Monitors 6.3 HIS/RIS/EMR, PACS, and CAD

7 Accreditation, MQSA, EQUIP, and Density Reporting

7.1 Accreditation Bodies, FDA/MQSA Personnel, Records, Audits, and Policies 7.2 EQUIP: QA Oversight, Clinical Image Quality, and Corrective Action 7.3 Breast Density Reporting Requirements

8 Quality Control Testing

8.1 Mammographer QC: Phantom Image, Compression Thickness, Visual Checklist 8.2 Mammographer QC: Monitors, Repeat Analysis, Viewing Conditions, Compression Force, Detector Calibration 8.3 Physicist Tests: MEE, Collimation, Spatial Resolution/MTF, SNR/CNR, AEC, AGD, kVp, HVL 8.4 Physicist Tests: Artifacts, Phantom Quality, Illuminance, Tech QC Program Review, Compression Application/Paddle Alignment, Workstation QC

9 Technique and Image Evaluation

9.1 Technical Factors: kVp, mAs, AEC vs Manual, Target/Filter, Focal Spot, Grid, Mag, Labeling 9.2 EQUIP Image-Quality Criteria 9.3 Patient-Related Artifacts

10 Localization and Anatomy

10.1 Clock Position, Quadrants, and Triangulation 10.2 External Anatomy 10.3 Internal Anatomy: Fascia, Glandular Tissue, and the TDLU 10.4 Cooper Ligaments, Pectoral Muscle, Vascular/Lymphatic Systems, and Cytology

11 BI-RADS Lexicon

11.1 Architectural Distortion, Asymmetry, and Mass Features 11.2 Calcification Morphology and Distribution 11.3 Assessment Categories, Breast Density, and Recommendations

12 Breast Pathology

12.1 Benign Pathology and Mammographic Appearance 12.2 Lesions with Upgrade Potential 12.3 DCIS, IDC, and Invasive Lobular Carcinoma 12.4 Inflammatory Carcinoma, Paget Disease, Sarcoma, Lymphoma, and Metastases

13 Standard Screening Views

13.1 Craniocaudal (CC) Positioning 13.2 Mediolateral Oblique (MLO) Positioning

14 Additional Views I

14.1 Mediolateral (ML) and Lateromedial (LM) 14.2 XCCL, XCCM, Cleavage (CV), and Axillary Tail (AT) 14.3 Tangential (TAN) and Rolled Views (RL, RM, RS, RI)

15 Additional Views II

15.1 Implant Displaced (ID), Nipple in Profile, and Anterior Compression 15.2 Spot Compression and Magnification

16 Patient Variance

16.1 Chest Wall Variations, Kyphosis/Lordosis, Protruding Abdomen, and Extreme Breast Size 16.2 Irradiated Breast, Reduction Mammoplasty, and Postsurgical Breast 16.3 Male Patients and Lactating Breast 16.4 Breast Augmentation and Implanted Devices

17 Imaging Examinations

17.1 Screening vs Diagnostic Mammography 17.2 Breast Ultrasound and Breast MRI

18 Interventional Procedures

18.1 History, Consent, Time-Out, Setup, and Postprocedure Instructions 18.2 Stereotactic and Ultrasound-Guided Biopsy 18.3 Needle Localization, Specimen Imaging, and Clip Placement 18.4 Handling and Disposing of Biohazardous Materials

18.2 Stereotactic and Ultrasound-Guided Biopsy

Key Takeaways Explain This Topic AI

Stereotactic core biopsy (upright or prone) is the method for calcifications and other mammographic-only targets; a scout image is followed by a stereo pair, and vacuum-assisted cores are commonly used.

Ultrasound-guided core biopsy is preferred for masses that are sonographically visible because the needle is watched in real time.

A tissue-marker clip is typically placed after percutaneous sampling so the site can be found if the original finding is gone.

Cyst aspiration and fine-needle aspiration biopsy were removed from ARRT Mammography Procedures in 2025; ultrasound guidance of a mass for core biopsy remains in.

If the scout does not show the target in the biopsy window, reposition — do not sample blindly.

Last updated: August 2026

Why Guidance Modality Is a High-Yield Item

The 2025 Task Inventory still asks you to assist with two biopsies: ultrasound core biopsy with clip placement and stereotactic core biopsy with clip placement (prone or upright) . ARRT tests basic knowledge: which method finds which target, what images prove you are on the finding, and what usually happens after the cores come out. The most common miss is treating ultrasound as a universal shortcut. Isolated mammographic calcifications do not become an ultrasound case "because ultrasound is real-time."

Keep the 2025 removals in view. Sentinel node mapping , cyst aspiration , and fine-needle aspiration (FNA) biopsy are not current mammography exam procedures. Ultrasound guidance of a mass for core biopsy is in. Do not confuse "this mass looks cystic on ultrasound" with "cyst aspiration is on the test."

Preparation, consent, and time-out for both rooms are in history, consent, time-out, setup, and postprocedure instructions . Clip films, core radiographs, and wire localization are in needle localization, specimen imaging, and clip placement .

Stereotactic Core Biopsy

Stereotactic guidance uses mammographic parallax. Two angled images let the system calculate the target's three-dimensional coordinates — X, Y, and depth (Z) — relative to the compressed breast in the biopsy window.

Scout, then stereo pair

The usual sequence is the sequence ARRT expects you to recognize:

Position the breast so the finding sits in the biopsy window.

Obtain a scout image (0°) and confirm the target is visible and not clipped by the window edge.

Obtain a stereo pair — classically two images about 15° to either side of the scout plane (±15°).

The physician (or targeting software under physician direction) marks the calcifications or mass on both stereo images.

The system computes coordinates and needle depth.

After the needle or vacuum probe is placed, repeat stereo images confirm that the aperture sits at the target before sampling.

If the scout does not show the finding, you do not biopsy. Reposition, change the projection (for example CC versus a lateral approach), or recognize that a tomosynthesis-only finding may need DBT-guided targeting rather than a 2D scout that never displayed the lesion. Stay at the basic level: stereotactic and tomosynthesis-guided work is for mammographic findings.

Upright versus prone

ARRT lists both platforms. Exam items often ask which one to choose, not how to service the table.

Platform Patient position Practical strengths Practical limits

Prone table Face-down; breast through an aperture Patient cannot see the needle; often fewer vasovagal events; breast hangs away from the chest wall Posterior, axillary, or very inferior lesions may be out of reach; some patients cannot lie prone (respiratory disease, kyphosis, recent abdominal surgery, table weight limits)

Upright (sitting or lateral decubitus) Seated or on the side, dedicated or add-on unit Better access to many posterior lesions; option when prone is impossible Vasovagal reactions are more common because the patient sees the work; motion if the patient is unsteady

A patient with isolated UOQ calcifications who cannot lie prone is not an automatic surgical biopsy. Upright or lateral-decubitus stereotactic biopsy is the usual next thought.

What stereotactic is for, and how you sample

Stereotactic (or tomosynthesis-guided) biopsy is the method of choice for calcifications and for masses, asymmetries, or architectural distortion seen only on mammography or DBT with no reliable ultrasound correlate.

Vacuum-assisted core sampling is commonly used, especially for calcifications. A vacuum-assisted probe can collect multiple cores through one insertion and retrieve the tiny calcium flecks that prove you hit the cluster. Spring-loaded cores that work well for a sonographic mass often undersample a calcification cluster. You do not need a brand name. You do need "vacuum-assisted core is the usual stereotactic tool for calcs."

Stroke margin is the distance from the target to the far skin (toward the image receptor). If the calculated throw would exit the breast, you do not fire. Change approach, compression, or needle geometry until the margin is safe.

After cores are taken, intraprocedural specimen radiographs of the cores confirm that calcifications are in the tissue. If they are not, the physician retargets or takes additional samples before the patient gets off the table. A clip is typically deployed at the cavity so the site can be found later if the mammographic finding is gone.

Ultrasound-Guided Core Biopsy

Ultrasound guidance is real-time . The physician watches the needle enter the mass on the monitor. That is the method of choice for sonographically visible masses (and other ultrasound-visible targets, such as a solid-appearing nodule or a clip that can be seen with ultrasound).

Typical set-up: patient supine or posterior oblique, arm above the head, lesion documented in two planes, sterile probe cover, local anesthetic, a small nick if a larger device is used, then cores. Many mass biopsies use a spring-loaded core needle; vacuum-assisted devices are also used under ultrasound, especially for small masses. You do not need to memorize every gauge. You do need to know that ultrasound core biopsy with clip placement is an assist procedure on the 2025 task list.

Because the needle is visible in real time, ultrasound is a poor choice for isolated mammographic calcifications that have no ultrasound mass. "I will just look with ultrasound" is not a substitute for stereotactic targeting.

What was removed — and what was not

Cyst aspiration as a standalone mammography exam procedure was removed in 2025. Do not study it as a current 2.D task. If a cystic component is encountered while sampling a mass, handle any fluid as a body fluid under biohazard handling and follow the physician's on-table decision. Do not treat diagnostic cyst aspiration as a listed mammography procedure.

FNA biopsy was likewise removed. Sentinel node mapping was removed from Procedures. Those three belong in your "do not pick this" pile when an older-looking option appears.

Clip Placement After Percutaneous Biopsy

After adequate sampling, a radiopaque tissue marker (clip) is usually placed at the biopsy cavity. Clips matter most when vacuum-assisted sampling removes most or all of a small finding: the clip may be the only future target for localization. Post-clip mammograms document where the clip sits relative to the original finding. Displacement along the compression axis after the breast is released is the accordion effect — a reason the post-clip mammogram can look "off" compared with stereo images obtained under compression. Imaging of that clip is tested with specimen and localization films in the next section.

Choosing the Table: Stereotactic Versus Ultrasound

Target type Preferred guidance Why

Isolated microcalcifications Stereotactic (prone or upright) Calcifications are mammographic findings; specimen radiographs prove they are in the cores

Mass, distortion, or asymmetry seen only on mammography/DBT Stereotactic or DBT-guided No reliable real-time ultrasound target

Mass clearly seen on ultrasound Ultrasound core biopsy Real-time needle visualization; no stereo pair required

Clip or cavity visible on ultrasound after a prior biopsy Ultrasound if visible; mammographic/stereotactic if not Use the modality that actually shows today's target

Realistic Exam Scenario

Screening shows a tight cluster of pleomorphic calcifications in the left breast at 10 o'clock, 8 cm from the nipple. Diagnostic mammography confirms the cluster. Ultrasound of that quadrant shows no mass. The correct assist procedure is stereotactic vacuum-assisted core biopsy with clip placement , not ultrasound core biopsy and not FNA. After cores, the mammographer radiographs the specimens. If no calcium is on that film, sampling is not finished.

Common Traps

Picking ultrasound for isolated calcifications.

Forgetting the scout-then-stereo-pair sequence.

Calling FNA or cyst aspiration a current ARRT mammography procedure.

Omitting clip placement after a vacuum-assisted biopsy that may remove the entire mammographic finding.

Firing when stroke margin is inadequate.